CBIO · Crescent Biopharma Inc. Common Stock
View on chartInsiders & Stakes
| Invus Public Equities, L.P. 10% Owner | ▼ Sell | Open Market | 6,317,565 Shares held | 8/8/2024 | View profile |
| Fairmount Funds Management LLC Director | ▲ Buy | Open Market | 3,601,316 Shares held | 7/16/2026 | View profile |
| Scott D. Sandell 10% Owner | ▼ Sell | Open Market | 2,237,196 Shares held | 1/26/2023 | View profile |
| Edwin Rock Chief Medical Officer | ▲ Buy | Open Market | 680,403 Shares held | 6/21/2024 | View profile |
| King Rachel K. Director | ▲ Buy | Grant | 515,194 Shares held | 3/29/2024 | View profile |
| Magnani John L. SVP of Research, CSO | ▲ Buy | Open Market | 366,078 Shares held | 11/11/2022 | View profile |
| Joshua T. Brumm CEO & President | ▼ Sell | Open Market | 281,212 Shares held | 6/22/2026 | View profile |
| Jonathan McNeill Chief Business Officer | ▼ Sell | Open Market | 139,158 Shares held | 6/22/2026 | View profile |
| Johnson Bruce S SVP & Chief Commercial Officer | ▲ Buy | Open Market | 138,980 Shares held | 5/8/2023 | View profile |
| Daniel M. Junius Director | ▲ Buy | Grant | 98,459 Shares held | 3/29/2024 | View profile |
| Brian M. Hahn SVP Finance, CFO | ▲ Buy | Open Market | 70,643 Shares held | 6/18/2024 | View profile |
| BVF PARTNERS L P/IL Director | ▼ Sell | Other | 62,383 Shares held | 6/13/2025 | View profile |
| Christopher Grant Doughty Chief Business Officer | ▲ Buy | Grant | 62,194 Shares held | 12/15/2025 | View profile |
| Patricia S. Andrews Director | ▲ Buy | Grant | 58,608 Shares held | 12/29/2023 | View profile |
| Koenig Scott Director | ▲ Buy | Option Exercise | 36,750 Shares held | 6/1/2023 | View profile |
| Girard Armand SVP, Chief Business Officer | ▲ Buy | Open Market | 29,161 Shares held | 11/11/2022 | View profile |
| Semerjian Harout Chief Executive Officer | ▲ Buy | Open Market | 25,000 Shares held | 11/11/2022 | View profile |
| Goldberg Mark Alan Director | ▲ Buy | Grant | 24,828 Shares held | 3/29/2024 | View profile |
| PEARSON TIMOTHY R Director | ▲ Buy | Open Market | 24,650 Shares held | 11/11/2022 | View profile |
| Jan Pinkas Chief Scientific Officer | ▼ Sell | Open Market | 22,239 Shares held | 6/22/2026 | View profile |
| Ellie Eunkyung Im Chief Medical Officer | ▼ Sell | Open Market | 22,069 Shares held | 6/22/2026 | View profile |
| Richard William Scalzo SVP, Head of Finance & Admin. | ▼ Sell | Open Market | 20,298 Shares held | 6/22/2026 | View profile |
| Barbara Harlin Bispham See Remarks | ▼ Sell | Open Market | 19,330 Shares held | 6/22/2026 | View profile |
| Ryan Lynch See Remarks | ▼ Sell | Open Market | 13,871 Shares held | 6/22/2026 | View profile |
Transaction History
| Fairmount Funds Management LLC | ▲ Buy | Open Market | 853,450 | $12.4M | 7/16/2026 |
| Ryan Lynch | ▼ Sell | Open Market | 465 | $8K | 6/22/2026 |
| Jan Pinkas | ▼ Sell | Open Market | 1,288 | $23K | 6/22/2026 |
| Richard William Scalzo | ▼ Sell | Open Market | 1,112 | $20K | 6/22/2026 |
| Ellie Eunkyung Im | ▼ Sell | Open Market | 1,219 | $22K | 6/22/2026 |
| Jonathan McNeill | ▼ Sell | Open Market | 20,549 | $370K | 6/22/2026 |
| Joshua T. Brumm | ▼ Sell | Open Market | 42,305 | $761K | 6/22/2026 |
| Barbara Harlin Bispham | ▼ Sell | Open Market | 1,218 | $22K | 6/22/2026 |
| Jan Pinkas | ▲ Buy | Grant | 17,507 | — | 12/15/2025 |
| Jan Pinkas | ▲ Buy | Grant | 5,000 | — | 12/15/2025 |
| Christopher Grant Doughty | ▲ Buy | Grant | 14,714 | — | 12/15/2025 |
| Christopher Grant Doughty | ▲ Buy | Grant | 8,000 | — | 12/15/2025 |
| Joshua T. Brumm | ▲ Buy | Grant | 45,117 | — | 12/15/2025 |
| Joshua T. Brumm | ▲ Buy | Grant | 10,000 | — | 12/15/2025 |
| Richard William Scalzo | ▲ Buy | Grant | 14,422 | — | 12/15/2025 |
| Richard William Scalzo | ▲ Buy | Grant | 5,000 | — | 12/15/2025 |
| Jonathan McNeill | ▲ Buy | Grant | 19,507 | — | 12/15/2025 |
| Jonathan McNeill | ▲ Buy | Grant | 6,000 | — | 12/15/2025 |
| Ellie Eunkyung Im | ▲ Buy | Grant | 16,298 | — | 12/15/2025 |
| Ellie Eunkyung Im | ▲ Buy | Grant | 5,000 | — | 12/15/2025 |
| Ryan Lynch | ▲ Buy | Grant | 8,378 | — | 12/15/2025 |
| Ryan Lynch | ▲ Buy | Grant | 4,000 | — | 12/15/2025 |
| Barbara Harlin Bispham | ▲ Buy | Grant | 12,422 | — | 12/15/2025 |
| Barbara Harlin Bispham | ▲ Buy | Grant | 6,000 | — | 12/15/2025 |
| Fairmount Funds Management LLC | ▲ Buy | Open Market | 1,360,000 | $18.2M | 12/4/2025 |
| BVF PARTNERS L P/IL | ▼ Sell | Other | 657,308 | — | 6/13/2025 |
| BVF PARTNERS L P/IL | ▼ Sell | Other | 556,617 | — | 6/13/2025 |
| BVF PARTNERS L P/IL | ▼ Sell | Other | 56,079 | — | 6/13/2025 |
| Invus Public Equities, L.P. | ▼ Sell | Open Market | 260,873 | $50K | 8/8/2024 |
| Invus Public Equities, L.P. | ▼ Sell | Open Market | 61,488 | $11K | 8/7/2024 |
| Invus Public Equities, L.P. | ▼ Sell | Open Market | 55,732 | $10K | 8/6/2024 |
| Invus Public Equities, L.P. | ▼ Sell | Open Market | 164,523 | $31K | 8/5/2024 |
| Invus Public Equities, L.P. | ▼ Sell | Open Market | 286,200 | $57K | 8/2/2024 |
| Invus Public Equities, L.P. | ▼ Sell | Open Market | 63,564 | $14K | 8/1/2024 |
| Invus Public Equities, L.P. | ▼ Sell | Open Market | 756,835 | $167K | 7/30/2024 |
| Invus Public Equities, L.P. | ▼ Sell | Open Market | 363,949 | $86K | 7/29/2024 |
| Invus Public Equities, L.P. | ▼ Sell | Open Market | 258,335 | $62K | 7/26/2024 |
| Edwin Rock | ▲ Buy | Open Market | 115,000 | $31K | 6/21/2024 |
| Edwin Rock | ▲ Buy | Open Market | 190,000 | $48K | 6/20/2024 |
| Brian M. Hahn | ▲ Buy | Open Market | 17,500 | $4K | 6/18/2024 |
| Daniel M. Junius | ▲ Buy | Grant | 5,209 | $16K | 3/29/2024 |
| King Rachel K. | ▲ Buy | Grant | 3,334 | $10K | 3/29/2024 |
| Goldberg Mark Alan | ▲ Buy | Grant | 4,584 | $14K | 3/29/2024 |
| Patricia S. Andrews | ▲ Buy | Grant | 5,191 | $12K | 12/29/2023 |
| King Rachel K. | ▲ Buy | Grant | 4,238 | $10K | 12/29/2023 |
| Goldberg Mark Alan | ▲ Buy | Grant | 5,827 | $14K | 12/29/2023 |
| Goldberg Mark Alan | ▲ Buy | Grant | 9,167 | $14K | 9/30/2023 |
| Patricia S. Andrews | ▲ Buy | Grant | 8,167 | $12K | 9/30/2023 |
| King Rachel K. | ▲ Buy | Grant | 6,667 | $10K | 9/30/2023 |
| Edwin Rock | ▲ Buy | Open Market | 30,403 | $42K | 9/22/2023 |
| Edwin Rock | ▲ Buy | Open Market | 35,000 | $48K | 9/21/2023 |
| Koenig Scott | ▲ Buy | Option Exercise | 21,000 | $13K | 6/1/2023 |
| Brian M. Hahn | ▼ Sell | Open Market | 3,700 | $7K | 5/17/2023 |
| Daniel M. Junius | ▲ Buy | Open Market | 30,000 | $47K | 5/10/2023 |
| Johnson Bruce S | ▲ Buy | Open Market | 13,500 | $21K | 5/8/2023 |
| Invus Public Equities, L.P. | ▲ Buy | Open Market | 100,000 | $170K | 2/24/2023 |
| Invus Public Equities, L.P. | ▲ Buy | Open Market | 200,000 | $351K | 2/23/2023 |
| Invus Public Equities, L.P. | ▲ Buy | Open Market | 150,000 | $269K | 2/22/2023 |
| Invus Public Equities, L.P. | ▲ Buy | Open Market | 50,000 | $93K | 2/21/2023 |
| Invus Public Equities, L.P. | ▲ Buy | Open Market | 200,000 | $341K | 2/17/2023 |
| Invus Public Equities, L.P. | ▲ Buy | Open Market | 315,266 | $531K | 2/16/2023 |
| Invus Public Equities, L.P. | ▲ Buy | Open Market | 1,000,000 | $2.2M | 2/15/2023 |
| Invus Public Equities, L.P. | ▲ Buy | Open Market | 11,451 | $37K | 2/9/2023 |
| Koenig Scott | ▲ Buy | Option Exercise | 10,500 | $27K | 1/27/2023 |
| Scott D. Sandell | ▼ Sell | Open Market | 1,648,908 | $5.1M | 1/26/2023 |
| Scott D. Sandell | ▼ Sell | Open Market | 1,351,092 | $4.2M | 1/26/2023 |
| Scott D. Sandell | ▼ Sell | Open Market | 358,371 | $1.2M | 1/25/2023 |
| Scott D. Sandell | ▼ Sell | Open Market | 293,645 | $958K | 1/25/2023 |
| Scott D. Sandell | ▼ Sell | Open Market | 39,223 | $108K | 1/5/2023 |
| Scott D. Sandell | ▼ Sell | Open Market | 32,139 | $89K | 1/5/2023 |
| Scott D. Sandell | ▼ Sell | Open Market | 56,054 | $163K | 1/4/2023 |
| Scott D. Sandell | ▼ Sell | Open Market | 45,930 | $134K | 1/4/2023 |
| Scott D. Sandell | ▼ Sell | Open Market | 96,084 | $287K | 1/3/2023 |
| Scott D. Sandell | ▼ Sell | Open Market | 78,730 | $235K | 1/3/2023 |
| Scott D. Sandell | ▼ Sell | Open Market | 66,690 | $201K | 12/30/2022 |
| Scott D. Sandell | ▼ Sell | Open Market | 54,645 | $165K | 12/30/2022 |
| Edwin Rock | ▲ Buy | Open Market | 110,000 | $248K | 12/22/2022 |
| Daniel M. Junius | ▲ Buy | Open Market | 20,000 | $37K | 11/17/2022 |
| Edwin Rock | ▲ Buy | Open Market | 100,000 | $166K | 11/15/2022 |
| Edwin Rock | ▲ Buy | Open Market | 100,000 | $143K | 11/14/2022 |
| Brian M. Hahn | ▲ Buy | Open Market | 20,000 | $21K | 11/11/2022 |
| Magnani John L. | ▲ Buy | Open Market | 45,045 | $53K | 11/11/2022 |
| Girard Armand | ▲ Buy | Open Market | 6,500 | $7K | 11/11/2022 |
| PEARSON TIMOTHY R | ▲ Buy | Open Market | 19,400 | $25K | 11/11/2022 |
| Semerjian Harout | ▲ Buy | Open Market | 25,000 | $32K | 11/11/2022 |
| Magnani John L. | ▼ Sell | Open Market | 3,227 | $4K | 3/9/2022 |
| Girard Armand | ▼ Sell | Open Market | 2,339 | $3K | 3/9/2022 |
| Brian M. Hahn | ▼ Sell | Open Market | 2,917 | $3K | 3/9/2022 |
| Patricia S. Andrews | ▲ Buy | Open Market | 40,000 | $82K | 11/16/2021 |